What is the annual revenue of Alnylam Sweden AB?

The Alnylam Sweden AB annual revenue is 100–500M SEK.

How many people are employed at Alnylam Sweden AB?

5–9 people are employed at Alnylam Sweden AB.

Where is Alnylam Sweden AB based?

Alnylam Sweden AB is based in STOCKHOLM, Sweden.

When was Alnylam Sweden AB founded?

Alnylam Sweden AB was founded in 2016.

What industry is Alnylam Sweden AB in?

Alnylam Sweden AB operates in the Partihandel med medicinsk utrustning och apoteksvaror industry.

What is Alnylam Sweden AB's website?

You can visit Alnylam Sweden AB's website at https://www.alnylam.se.

Alnylam Sweden AB

559086-6686Active

Leading RNAi therapeutics company developing gene-silencing medicines.

Biopharmaceutical Companyalnylam.se

5–9
Employees: 100–500M SEK
Revenue: 2016
Founded

Key Decision Makers

Jeff Poulton

Chief Financial Officer

Hiroshi Okada

President, Alnylam Japan

Bryan Supran

Chief Legal Officer

Pushkal Garg

Chief Research and Development Officer

+19 more contacts in Funnelfeedr

Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...

Alnylam Sweden AB

Key Decision Makers

Tags

Keywords

Tech Stack

Company Information

Decision Makers

Other Contacts

Similar Companies

Alexion Pharma Nordics AB

Purpose Pharma International AB

PTC Therapeutics Sweden AB

ASTRAZENECA PLC

ScandiBio Therapeutics AB

Browse More